← Back to Screener
Alpha Tau Medical Ltd. Warrant (DRTSW)
Price$1.02
Favorite Metrics
Price vs S&P 500 (26W)211.25%
Price vs S&P 500 (4W)-12.41%
All Metrics
Price vs S&P 500 (YTD)189.98%
10-Day Avg Trading Volume0.06M
3-Month Avg Trading Volume0.04M
52-Week High$1.50
26-Week Price Return220.00%
13-Week Price Return4.28%
3-Month Return Std Dev164.54%
Year-to-Date Return194.12%
5-Day Price Return21.64%
Month-to-Date Return0.00%
Price vs S&P 500 (13W)1.41%
Beta2.20x
52-Week Low$0.18
Industry Peers — Surgical & Medical Instruments(109)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
DRTSWAlpha Tau Medical Ltd. Warrant | — | — | — | — | $1.02 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Alpha Tau Medical is a clinical-stage oncology company developing Alpha DaRT, a proprietary alpha particle technology designed for targeted radiation therapy of solid tumors. The platform combines the therapeutic benefits of alpha radiation with a solution to its traditionally limited range. The Israel-based company is advancing its pipeline toward clinical applications in cancer treatment.